Fareen Momen

Michigan Medicine

Papers

1

Total Citations

4

H-Index

1

About

Dr. Fareen Momen is a dedicated researcher whose work focuses on the devastating pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG). Her primary contributions center on advancing diagnostic techniques and exploring experimental therapies for this universally fatal disease, which has a median survival of just 8-12 months. In her highly cited 2025 paper, "Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma," Dr. Momen highlights the critical shift from traditional MRI-based diagnosis toward more precise, biopsy-driven approaches. This work underscores her commitment to improving both diagnostic accuracy and treatment outcomes for children with DIPG, a condition that has historically seen little progress. With 4 citations already, her research is gaining traction in the neuro-oncology community. Dr. Momen’s efforts are particularly notable for addressing a rare cancer where the need for innovation is urgent, and her work offers hope for families facing this devastating diagnosis. Her dedication to translating laboratory findings into clinical possibilities marks her as a rising voice in pediatric neuro-oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Michigan Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago